Study Evaluating Anxiety and Depression in Patients With Psoriatic Arthritis

Anxiety and Depression in Patients With Psoriatic Arthritis: Prevalence and Characteristics

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00884468

Enrollment

384

Registered

2009-04-20

Start date

2008-05-31

Completion date

2008-12-31

Last updated

2009-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psoriatic Arthritis

Keywords

Anxiety and depression in patients with psoriatic arthritis

Brief summary

This is an epidemiological non-interventional study assessing the prevalence of anxiety and/or depression disorders in patients suffering from Psoriatic Arthritis (PsA) in Spain.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients both genders over 18 years old * Patients with PsA diagnosis

Exclusion criteria

* Patients with PsA that suffer from other rheumatologic diseases or non-concomitant rheumatologic diseases that the investigator considers not to be appropriate for the study. * Patients with any medical or physical condition (cognitive damage or difficulties for understanding) that create difficulties for reading and completing the questionnaires described in the protocol. * Patients that in the study period are taking part in another clinical trial.

Design outcomes

Primary

Measure	Time frame
Prevalence of anxiety and/or depression disorders in patients suffering from PsA in Spain as measured by the Hospital Anxiety and Depression Scale (HAD)	12 months

Secondary

Measure	Time frame
To assess the relation between the PsA severity and the presence of anxiety and/or depression disorders in patients suffering from PsA in Spain.	12 months

Countries

Spain

Outcome results